表紙
市場調査レポート

ドラッグデリバリー技術 (薬物送達技術) 市場の予測:主要企業の市場機会 2015-2025

Drug Delivery Technologies Market Forecast 2015-2025: Prospects for Leading Companies

発行 Visiongain Ltd 商品コード 233148
出版日 ページ情報 英文 204 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1GBP=144.09円で換算しております。

ご注意:
Single UserとDepartmentalライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[?]アイコンをクリックしてご確認ください。

Back to Top
ドラッグデリバリー技術 (薬物送達技術) 市場の予測:主要企業の市場機会 2015-2025 Drug Delivery Technologies Market Forecast 2015-2025: Prospects for Leading Companies
出版日: 2015年06月16日 ページ情報: 英文 204 Pages
概要

世界のドラッグデリバリー技術市場における収益は2015年に1593億米ドルに達すると見込まれ、2015年から2025年は安定した収益増加が予測されています。

当レポートでは、世界のドラッグデリバリー技術 (薬物送達技術) 技術市場を取り上げ、主要なドラッグデリバリー技術、2次市場および主要国市場における動向および予測を提示するとともに、主要企業のプロファイル、SWOT分析および専門家の見解をまとめています。

第1章 レポートの概要

  • 世界のドラッグデリバリー技術 (薬物送達技術) 市場の概要
  • 調査結果の概要
  • レポートの構成
  • 世界のドラッグデリバリー技術市場の区分
  • 当レポートを推奨する理由
  • 当レポートの提供方法
  • この解析レポートが解明する主な疑問
  • 対象読者
  • 調査手法
  • よく聞かれる質問 (FAQ)
  • 関連レポート
  • Visiongainについて

第2章 ドラッグデリバリー技術のイントロダクション

  • ドラッグデリバリー技術 (DDT)
  • 持続/制御放出システム
  • バイオ医薬品 (生物薬剤)
  • 市場の定義

第3章 ドラッグデリバリー技術:世界市場

  • 世界のドラッグデリバリー技術市場:概要
  • 世界のドラッグデリバリー技術市場
  • 世界のドラッグデリバリー技術市場予測
  • 区分別市場シェアの変化予測
  • 生物製剤:ドラッグデリバリー技術の成長促進因子
  • ワクチン:アンメットニーズへの対応
  • ドラッグデリバリー技術:促進因子・阻害因子

第4章 ドラッグデリバリー技術の2次市場

  • 経口薬デリバリー技術
  • 吸入薬デリバリー技術
  • 注射/インプラントデリバリー技術
  • 経皮薬デリバリー技術
  • 眼薬デリバリー技術
  • 経鼻/口腔薬デリバリー技術

第5章 主要国市場

  • 世界のドラッグデリバリー技術市場:地域別の予測
    • 市場シェアの推移予測
  • 米国のドラッグデリバリー技術市場
    • 市場予測
    • コンビネーション製品に対するFDAのガイドライン
    • Eli Lilly はドラッグデリバリーセンターを設立
  • EU5カ国のドラッグデリバリー技術市場
    • 市場予測
    • 市場シェアの推移予測
    • ドイツ
    • フランス
    • 英国
    • スペイン
    • イタリア
  • 日本のドラッグデリバリー技術市場
  • 中国のドラッグデリバリー技術市場
  • インドのドラッグデリバリー技術市場
  • ブラジルのドラッグデリバリー技術市場
  • ロシアのドラッグデリバリー技術市場
  • 韓国のドラッグデリバリー技術市場
  • メキシコのドラッグデリバリー技術市場
  • その他のドラッグデリバリー技術市場

第6章 ドラッグデリバリー技術市場における主要企業

  • Alkermes
  • 3M
  • Skyepharma
  • BD
  • Antares Pharma
  • pSivida
  • Applied Pharma Research (APR)
  • Ethypharm
  • Glycologic
  • Nanopass Technologies

第7章 ドラッグデリバリー技術市場の定性分析

  • ドラッグデリバリー技術市場のSWOT分析
  • 強み
  • 弱み
  • 機会
  • 脅威

第8章 専門家の見解

第9章 総括

  • 世界のドラッグデリバリー技術市場
    • 現在の主なドラッグデリバリー技術区分
    • 注目のドラッグデリバリー技術企業
    • 主な地域市場
  • 世界のドラッグデリバリー技術市場予測
  • ドラッグデリバリー技術市場の将来
    • 経皮薬・注射薬デリバリー技術が高成長の構え
    • 生物薬剤・バイオシミラーは市場成長を促進

第10章 用語

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: PHA0050

Drug Delivery Technology - assess products, developments, and revenue prospects

What does the future hold for the drug delivery technologies market? Visiongain's brand new report shows you potential revenues to 2025, assessing data, trends, opportunities and prospects.

Our 204 page report provides 113 tables, charts, and graphs covering 6 leading and distinct submarkets. Discover the most lucrative areas in the industry and the future market prospects. You will see financial results, interviews, trends, opportunities, and revenue predictions. Increasing development and use of biological drugs (biologics) will increase worldwide sales of drug delivery technologies from 2015 to 2025, our study shows.

Forecasts from 2015-2025 and other analyses show you commercial prospects

Besides revenue forecasting to 2025, our new study provides you with recent results, growth rates, and market shares. You will find original analyses, with business outlooks and developments. Discover qualitative analyses (including SWOT), company profiles and commercial developments. Read the full transcript of 5 exclusive expert opinion interviews from industry specialists informing your understanding and allowing you to assess prospects for investments and sales:

  • Dr Igor Gonda, President and CEO & David Cipolla, Senior Director of Pharmaceutical Sciences, Aradigm
  • Dr Claus Michael Lehr, Head of Department, Drug Delivery at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)
  • Dr. Bridget Martell, Chief Medical Officer and Vice President of Clinical Product Development, Juniper Pharmaceuticals
  • John McCarter, Director of Business Development, Soluble Therapeutics
  • Dr Sven Frokjaer, Dean and Professor of Pharmaceutical Sciences, University of Copenhagen, Denmark

You will find prospects for key submarkets

In addition to analyses of the overall world market, you will see revenue forecasting of 6 major submarkets to 2025:

  • Oral Drug Delivery Market Forecast 2015-2025
  • Inhalable Drug Delivery Market Forecast 2015-2025
  • Injectable/Implantable Drug Delivery Market Forecast 2015-2025
  • Transdermal Drug Delivery Market Forecast 2015-2025
  • Ocular Drug Delivery Market Forecast 2015-2025
  • Nasal/Buccal Drug Delivery Market Forecast 2015-2025

image1

Our new study also provides qualitative analyses for each submarket identifying strengths, weaknesses, opportunities and potential threats to sales growth.

How will those drug delivery markets expand? Which applications will generate the most money? This study will allow you to thoroughly understand the industry, finding the most promising places for investments and sales.

What are the prospects in the leading regions and countries?

In our study you will find individual revenue forecasts to 2025 for the leading regional and national markets:

  • US
  • Japan
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • China
  • India
  • Brazil
  • Russia
  • South Korea
  • Mexico
  • Rest of the World

image2

Many opportunities exist within the drug delivery technologies market. With our new investigation you will gain business research and analysis with individual sales predictions and discussions. You will find analysis of competition, as well as commercial drivers and restraints.

Leading companies and potential for market growth

Overall world revenue for the drug delivery technologies market will reach $159.3bn in 2015, our work forecasts. We predict strong revenue growth from 2015 to 2025. Our work shows you what organisations hold greatest potential. See profiles of 10 leading companies and others, including:

  • Alkermes
  • 3M
  • Skyepharma
  • BD
  • Antares Pharma
  • pSivida
  • Applied Pharma Research
  • Ethypharm
  • Glycologic
  • NanoPass Technologies

In general, a company profile gives you the following information:

  • Overview of the company, including its history in the drug delivery technology market
  • Discussion of a company's activities and outlook including descriptions of leading products
  • Recent financial results
  • Assessment of recent developments - mergers and acquisitions (M&A), new products, and collaborations, inc. alliances, partnerships and joint ventures

image3

What issues will affect the drug delivery technology market?

Our new report discusses issues and events affecting the drug delivery technology market. You will find discussions, including qualitative analyses:

  • Product life cycle extension
  • The strong growth of biologics
  • Trends toward self administration
  • Aging population
  • Rising incidence of chronic diseases such as diabetes

Technologies and applications giving improved clinical efficacy, patient convenience and treatment compliance will achieve success. In particular, greater use of injectable drugs and vaccines worldwide will stimulate demand for innovative delivery systems.

You will see discussions of technological, commercial, and economic matters, with emphasis on the competitive landscape and business outlooks.

How the Drug Delivery Technologies Market Forecast 2015-2025: Prospects for Leading Companies report helps you

In summary, our 204 page report gives you the following knowledge:

  • Revenue forecasts to 2025 for the overall world drug delivery technology market and 6 submarkets - discover the industry's prospects, finding promising places for investments and revenues
  • Assessment of leading companies, and others, discovering activities and outlooks
  • Market forecasting to 2025 for the leading regional and national markets - US, Japan, Germany, France, UK, Spain, Italy, China, India, Brazil, Russia, South Korea, Mexico and RoW
  • View opinions from our survey, seeing interviews with authorities
  • Investigation of competition and opportunities influencing sales
  • Discussion of what stimulates and restrains the drug delivery technology market

You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the drug delivery technologies market. You find data, trends and predictions. Please order our report now.

Table of Contents

1. Report Overview

  • 1.1 Global Drug Delivery Technology Market Overview
  • 1.2 Overview of Findings
  • 1.3 Structure of the Report
  • 1.4 Global Drug Delivery Technology Market Segmentation
  • 1.5 Why You Should Read This Report
  • 1.6 How This Report Delivers
  • 1.7 Key Questions Answered by This Analytical Report
  • 1.8 Who is This Report For?
  • 1.9 Methodology
  • 1.10 Frequently Asked Questions (FAQ)
  • 1.11 Associated Visiongain Reports
  • 1.12 About Visiongain

2. Introduction to Drug Delivery Technology

  • 2.1 Drug Delivery Technologies (DDT)
    • 2.1.1 Oral Drug Delivery: Enter Through the Mouth
    • 2.1.2 Pulmonary Delivery: Delivered by Inhalation
    • 2.1.3 Injection as a Route of Drug Delivery
    • 2.1.4 Transdermal Delivery: More Patient-Friendly
    • 2.1.5 Various Transmucosal Delivery Routes for Delivery
    • 2.1.6 Ocular Delivery: Overcoming Unique Barriers
  • 2.2 Sustained/Controlled Release Systems
  • 2.3 Biopharmaceuticals
    • 2.3.1 An introduction to the Biological Drugs Market
    • 2.3.2 Biologics: A Rising Drugs Market
    • 2.3.3 Biotech Drugs with Associated Drug Delivery Technologies
    • 2.3.4 Pegylated Interferons
    • 2.3.5 Stiff Competition in Insulin Market Stimulating Investment in Drug Delivery Technologies
    • 2.3.6 The Main Challenges Facing Biological Drug Delivery
  • 2.4 Market Definition

3. Drug Delivery Technology: World Market 2015-2025

  • 3.1 The Global Drug Delivery Technology Market: Overview
  • 3.2 The Global Drug Delivery Technologies Market in 2014
  • 3.3 The Global Drug Delivery Technology Market Forecast 2015-2025
  • 3.4 How Will Segmental Market Shares Change to 2025?
  • 3.5 Biologics: A Driver for Growth in Drug Delivery Technologies
    • 3.5.1 The Global Biological Drugs Market Forecast
    • 3.5.2 Leading Classes of Biological Drugs
    • 3.5.3 Monoclonal Antibodies: Largest Sector in Biologics
    • 3.5.4 Human insulin: Leading the Therapeutic Protein Segment
    • 3.5.5 Interferon Products for the Treatment of Hepatitis
  • 3.6 Vaccines: Meeting the Unmet Needs
    • 3.6.1 The Global Vaccines Market Forecast
  • 3.7 Drug Delivery Technology: Drivers and Restraints 2015-2025

4. Drug Delivery Technologies Submarkets 2015-2025

  • 4.1 Oral Drug Delivery Technology
    • 4.1.1 Oral Drug Delivery Technology Market Forecast 2015-2025
    • 4.1.2 Trends and Developments
      • 4.1.2.1 Delivering APIs to the Colon
      • 4.1.2.2 Google Investing on Robotic Pill
      • 4.1.2.3 Better Tools to Model Drug Absorption
    • 4.1.3 Oral Drug Delivery Technologies: Drivers and Restraints 2015-2025
  • 4.2 Inhalable Drug Delivery Technology
    • 4.2.1 Inhalable Drug Delivery Technology Market Forecast 2015-2025
    • 4.2.2 Trends and Developments
      • 4.2.2.1 Inhalable Liposomal Antibiotics to Penetrate Biofilms
      • 4.2.2.2 Condensation Aerosol Generated by Heat
      • 4.2.2.3 Inhaled Insulin: Will It Succeed This Time?
    • 4.2.3 Inhalable Drug Delivery Technologies: Drivers and Restraints 2015-2025
  • 4.3 Injectable/Implantable Delivery Technology
    • 4.3.1 Injectable/Implantable Delivery Technology Market Forecast 2015-2025
    • 4.3.2 Trends and Developments
      • 4.3.2.1 Ultrasound Activated Targeted Drug Delivery
      • 4.3.2.2 Intradermal Vaccine Delivery
      • 4.3.2.3 First Flu Vaccine Jet Injector Approved in the US
    • 4.3.3 Injectable/Implantable Delivery Technologies: Drivers and Restraints 2015-2025
  • 4.4 Transdermal Drug Delivery Technology
    • 4.4.1 Transdermal Drug Delivery Technology Market Forecast 2015-2025
    • 4.4.2 Trends and Developments
      • 4.4.2.1 Iontophoretic Transdermal Patch for Migraine Approved in the US
      • 4.4.2.2 Microneedle Patch for Vaccine Delivery
      • 4.4.2.3 Ultrasonic Waveforms to Enlarge Skin Pores
  • 4.5 Ocular Drug Delivery Technology
    • 4.5.1 Ocular Drug Delivery Technology Market Forecast 2015-2025
    • 4.5.2 Trends and Developments
      • 4.5.2.1 Non-Surgical Microinjection to Retina and Choroid to be used for Gene Therapy
  • 4.6 Nasal/Buccal Drug Delivery Technology
    • 4.6.1 Nasal/Buccal Drug Delivery Technology Market Forecast 2015-2025
    • 4.6.2 Trends and Developments
      • 4.6.2.1 Nasal Spray with Live Attenuated Influenza Vaccine
      • 4.6.2.2 Mucosal Vaccine Delivered through Nose or Mouth
      • 4.6.2.3 Buccal Insulin Spray in Clinical Trials

5. Leading National Markets 2015-2025

  • 5.1 World Drug Delivery Technology Market: Regional Forecast 2015-2025
    • 5.1.1 How Will Regional Market Shares Change to 2025?
  • 5.2 US Drug Delivery Technology Market 2015-2025
    • 5.2.1 US Drug Delivery Technology Market Forecast 2015-2025
    • 5.2.2 FDA Guideline for Combination Products
    • 5.2.3 Eli Lilly to Establish Drug Delivery Centre
  • 5.3 EU5 Drug Delivery Technology Market 2015-2025
    • 5.3.1 EU5 Drug Delivery Technology Market Forecast 2015-2025
    • 5.3.2 How Will the European National Market Shares Change to 2025?
    • 5.3.3 The German Drug Delivery Technology Market Forecast 2015-2025
    • 5.3.4 The French Drug Delivery Technology Market Forecast 2015-2025
    • 5.3.5 The UK Drug Delivery Technology Market Forecast 2015-2025
    • 5.3.6 The Spanish Drug Delivery Technology Market Forecast 2015-2025
    • 5.3.7 The Italian Drug Delivery Technology Market Forecast 2015-2025
  • 5.4 Japanese Drug Delivery Technology Market 2015-2025
    • 5.4.1 Japanese Drug Delivery Technology Market Forecast 2015-2025
    • 5.4.2 The New Sakigake Designation System May Accelerate Innovative Drug Development
  • 5.5 Chinese Drug Delivery Technology Market 2015-2025
    • 5.5.1 Chinese Drug Delivery Technology Market Forecast 2015-2025
  • 5.6 Indian Drug Delivery Technology Market 2015-2025
    • 5.6.1 Indian Drug Delivery Technology Market Forecast 2015-2025
  • 5.7 Brazilian Drug Delivery Technology Market 2015-2025
    • 5.7.1 Brazilian Drug Delivery Technology Market Forecast 2015-2025
  • 5.8 Russian Drug Delivery Technology Market 2015-2025
    • 5.8.1 Russian Drug Delivery Technology Market Forecast 2015-2025
  • 5.9 South Korean Drug Delivery Technology Market 2015-2025
    • 5.9.1 South Korean Drug Delivery Technology Market Forecast 2015-2025
  • 5.10 Mexican Drug Delivery Technology Market 2015-2025
    • 5.10.1 Mexican Drug Delivery Technology Market Forecast 2015-2025
  • 5.11 Rest of the World Drug Delivery Technology Market 2015-2025
    • 5.11.1 Rest of the World Drug Delivery Technology Market Forecast 2015-2025

6. Leading Companies in the Drug Delivery Technology Market 2015

  • 6.1 Alkermes: Focused on Extended and Controlled Release
    • 6.1.1 Alkermes: Drug Delivery Technology Portfolio
      • 6.1.1.1 Long-Acting Injectables
      • 6.1.1.2 Oral Controlled Release
      • 6.1.1.3 Nanoparticle
      • 6.1.1.4 Other Technologies
    • 6.1.2 Alkermes: Product Portfolio
    • 6.1.3 Alkermes: Pipeline Products 2015
    • 6.1.4 Alkermes: Future Outlook
    • 6.1.5 Manufacturing Facility in Georgia Sold to Recro Pharma
  • 6.2 3M: 50 Years of Drug Delivery Technology Development
    • 6.2.1 3M: Drug Delivery Technology Portfolio
      • 6.2.1.1 Oral and Topical Drug Delivery
      • 6.2.1.2 MDI for Nasal and Inhalable Drugs
      • 6.2.1.3 Transdermal patch Technology
      • 6.2.1.4 Microneedle Technology
    • 6.2.2 3M: Future Outlook
  • 6.3 Skyepharma: Solutions for Inhalable, Oral, Topical and Injectable Drugs
    • 6.3.1 Skyepharma: Drug Delivery Technology Portfolio
      • 6.3.1.1 Inhalation Drug Delivery Technology
      • 6.3.1.2 Oral Drug Delivery Technology
      • 6.3.1.3 Injectable Drug Delivery Technology
      • 6.3.1.4 Topical Drug Delivery Technology
    • 6.3.2 Skyepharma: Pipeline Products 2015
    • 6.3.3 Skyepharma: Future Outlook
  • 6.4 BD: A History of Hypodermic Needles and Syringes
    • 6.4.1 BD: Drug Delivery Technology Portfolio
      • 6.4.1.1 Prefillable Syringe Systems
      • 6.4.1.2 Self-Injection Systems
      • 6.4.1.3 Pen Needles
      • 6.4.1.4 Safety & Shielding Systems
    • 6.4.2 BD: Future Outlook
    • 6.4.3 New Infusion Set with BD FlowSmart Technology Cleared by FDA
    • 6.4.4 BD Acquired Injection Safety Firms
  • 6.5 Antares Pharma: Leading the Needle-Free Injector Market
    • 6.5.1 Antares Pharma: Drug Delivery Product Portfolio
    • 6.5.2 Antares Pharma: Future Outlook
    • 6.5.3 Antares Pharma: Products in Development
  • 6.6 pSivida: Targeting the Back of the Eye
    • 6.6.1 pSivida: Drug Delivery Technology Portfolio
      • 6.6.1.1 Durasert Technology
      • 6.6.1.2 Tethadur Technology
    • 6.6.2 pSivida: Pipeline Products 2015
    • 6.6.3 psidiva: Collaborations
    • 6.6.4 pSivida: Future Outlook
    • 6.6.5 New Funded Technology Evaluation Agreements
  • 6.7 Applied Pharma Research (APR)
    • 6.7.1 APR's Technology and Product Offerings
  • 6.8 Ethypharm
    • 6.8.1 Ethypharm's Currently Marketed Products
  • 6.9 Glycologic
    • 6.9.1 Glycologic's Drug Delivery Technologies
    • 6.9.2 Glycologic's Pipeline Developments
  • 6.10 Nanopass Technologies
    • 6.10.1 Nanopass Drug Delivery Products
      • 6.10.1.1 Anti-aging Microdermabrasion
      • 6.10.1.2 Micronjet Needle

7. Qualitative Analysis of the Drug Delivery Technology Market 2015-2025

  • 7.1 SWOT Analysis of the Drug Delivery Technology Market
  • 7.2 Strengths
    • 7.2.1 Increasing Competition and Patent Expiry in the Biologics Market
    • 7.2.2 The Rise of Biosimilars
    • 7.2.3 Increasing Global Diabetes Population
  • 7.3 Weaknesses
    • 7.3.1 Risk-Conscious Regulatory Bodies Will Make Approval Difficult
    • 7.3.2 Companies Need to Develop a More Liberal Mindset
  • 7.4 Opportunities
    • 7.4.1 Nanotechnology: Innovations That Will Benefit Drug Delivery
    • 7.4.2 Possible New Delivery Methods for Insulin
  • 7.5 Threats
    • 7.5.1 Increasing Specificity of Drug Development Poses Challenges to Speciality Drug Delivery Companies
    • 7.5.2 Cost effective Solutions May not be Available

8. Research Interviews

  • 8.1 Dr Igor Gonda, President and CEO & David Cipolla, Senior Director of Pharmaceutical Sciences, Aradigm
    • 8.1.1 Aradigm and the AERx Pulmonary Drug Delivery Platform
    • 8.1.2 The Need for Innovative Pulmonary Delivery Technologies
    • 8.1.3 On the Competitive Landscape for the Pulmonary Drug Delivery Technology
    • 8.1.4 Asthma and COPD Lead, Serious Lung Infections to Catch Up
    • 8.1.5 On Global Reach and Licensing Opportunities
  • 8.2 Dr Claus Michael Lehr, Head of Department, Drug Delivery at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)
    • 8.2.1 The Need for Novel Delivery Mechanisms Driving Growth
    • 8.2.2 Therapeutic Areas That Are Propelling Drug Delivery Technologies
    • 8.2.3 Drug Delivery Barriers and the Need for Targeting
    • 8.2.4 Advancements in Drug Delivery in the Coming Years
    • 8.2.5 Future Challenges for Drug Delivery Technologies
    • 8.2.6 Future Opportunities for Drug Delivery Technologies
  • 8.3 Dr. Bridget Martell, Chief Medical Officer and Vice President of Clinical Product Development, Juniper Pharmaceuticals
    • 8.3.1 Focused on Women's Health and Drug Delivery
    • 8.3.2 On Competitive Landscape for Vaginally-Administered Products
    • 8.3.3 Unique Segmented IVR Technology
    • 8.3.4 Therapeutic Areas of BDS and IVR Technologies
    • 8.3.5 Pipeline Candidate Addressing Unmet Needs
    • 8.3.6 On Trends and Developments of the Market
  • 8.4 John McCarter, Director of Business Development, Soluble Therapeutics
    • 8.4.1 Focused on Biologics Formulation Screening Technology
    • 8.4.2 On Trends and Developments in the Market
    • 8.4.3 The HSC Technology is Faster and Cheaper with Lower Protein Consumption
    • 8.4.4 Patient Convenience is the Key
    • 8.4.5 On Important Therapeutic Areas
  • 8.5 Dr Sven Frokjaer, Dean and Professor of Pharmaceutical Sciences, University of Copenhagen, Denmark
    • 8.5.1 On the Current State of Drug Delivery Technologies
    • 8.5.2 The 'Magic Bullet' - A Challenge for Innovation
    • 8.5.3 Self-Assembling Protein Systems and the Use of Nanostructures for Drug Targeting
    • 8.5.4 Technological Developments in Drug Development - Quantum Dots, Silicon Structures, and Polymeric Materials
    • 8.5.5 On Future Challenges and Opportunities

9. Conclusions

  • 9.1 The World Drug Delivery Technology Market in 2014
    • 9.1.1 Current Leading Drug Delivery Technology Segments
    • 9.1.2 Notable Drug Delivery Technology Companies
    • 9.1.3 Leading Regional Markets
  • 9.2 World Drug Delivery Technology Market Forecast 2015-2025
  • 9.3 The Future of the Drug Delivery Technology Market
    • 9.3.1 Transdermal and Injectable Drug Delivery Technologies Set For High Growth
    • 9.3.2 Biologics and Biosimilars to Drive Market Growth

10. Glossary

List of Tables

  • Table 1.1 Leading National Drug Delivery Technology Market Forecast 2015-2025 ($bn, AGR%, CAGR%)
  • Table 2.1 Top 8 Biotech Drugs by Sales ($bn), 2014
  • Table 2.2 Top 8 Companies by Biologic Sales ($bn), 2014
  • Table 3.1 The Drug Delivery Technology Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025
  • Table 3.2 Global Biological Drugs Market: Revenues ($bn), AGR (%), CAGR (%), 2012-2023
  • Table 3.3 Global Vaccines Market: Revenues ($bn), AGR (%), CAGR (%), 2014-2025
  • Table 4.1 Oral Drug Delivery Technology Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025
  • Table 4.2 Inhalable Drug Delivery Technology Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025
  • Table 4.3 Insulin Inhalers Withdrawal from the Market or Pipeline, 2015
  • Table 4.4 Injectable/Implantable Drug Delivery Technology Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025
  • Table 4.5 Transdermal Drug Delivery Technology Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025
  • Table 4.6 Ocular Drug Delivery Technology Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025
  • Table 4.7 Nasal/Buccal Drug Delivery Technology Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025
  • Table 5.1 World Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), CAGR (%) by Region, 2014-2025
  • Table 5.2 US Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2014-2025
  • Table 5.3 EU5 Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2014-2025
  • Table 5.4 German Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2014-2025
  • Table 5.5 French Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2014-2025
  • Table 5.6 UK Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2014-2025
  • Table 5.7 Spanish Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2014-2025
  • Table 5.8 Italian Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2014-2025
  • Table 5.9 Japanese Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2014-2025
  • Table 5.10 Chinese Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2014-2025
  • Table 5.11 Indian Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2014-2025
  • Table 5.12 Brazilian Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2014-2025
  • Table 5.13 Russian Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2014-2025
  • Table 5.14 South Korean Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2014-2025
  • Table 5.15 Mexican Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2014-2025
  • Table 5.16 Rest of the World Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2014-2025
  • Table 6.1 Leading Companies: Areas of Interest by Type of Delivery
  • Table 6.2 Alkermes: Overview, 2015
  • Table 6.3 Alkermes: Drug Delivery Technology Portfolio and Pipeline 2015
  • Table 6.4 Products Utilising Alkermes' Drug Delivery Technology (Indication, Partner and Territory) 2015
  • Table 6.5 Alkermes: Pipeline Products (Product Candidate, Target Indication, Status), 2015
  • Table 6.6 Alkermes: Revenue ($m), AGR (%), CAGR (%), 2010-2014
  • Table 6.7 Alkermes: Revenue ($m) by Business Segment, 2010-2014
  • Table 6.8 3M: Overview, 2015
  • Table 6.9 3M: Health Care Revenue ($m), AGR (%), CAGR (%), 2009-2014
  • Table 6.10 Skyepharma: Overview, 2015
  • Table 6.11 Skyepharma: Inhalation Drug Formulation Technology Portfolio 2015
  • Table 6.12 Products Utilising Skyepharma's Inhalation Drug Delivery Technology (Product Name, Indication, Licensee, Description), 2015
  • Table 6.13 Skyepharma: Oral Drug Formulation Technology Portfolio (Technology, Description, Product name) 2015
  • Table 6.14 Products Utilising Skyepharma's Oral Drug Delivery Technology (Product name, Indication, Licensee, Description), 2015
  • Table 6.15 Skyepharma: Pipeline Products 2015 (Product name, Formulation, Indication, Status, Partner Name)
  • Table 6.16 Skyepharma: Revenue ($m), AGR (%), CAGR (%), 2010-2014
  • Table 6.17 Skyepharma: Revenue ($m) by Income Stream, 2010-2014
  • Table 6.18 BD: Overview, 2015
  • Table 6.19 BD: Drug Delivery Products by Segment, 2015
  • Table 6.20 BD: Revenue ($bn) by Geographic Region, 2012-2014
  • Table 6.21 BD Medical: Revenue ($m), AGR (%), CAGR (%), 2009-2014
  • Table 6.22 Antares Pharma: Overview, 2015
  • Table 6.23 Antares Pharma: Product Portfolio 2015 (Product, Drug, Partner, Indication, Territory)
  • Table 6.24 Antares' Revenue ($m) from Major Customers, 2010-2014
  • Table 6.25 Antares Pharma: Revenue ($m), AGR (%), CAGR (%), 2010-2014
  • Table 6.26 Antares Pharma: Products in Development 2015 (Product Name, Drug, Partner, Indication, Territory, Status)
  • Table 6.27 pSivida: Overview, 2015
  • Table 6.28 Products Utilising Durasert Technology 2015 (Product, Indication, Status, Partner)
  • Table 6.29 pSivida: Revenue ($m) by Income Stream, 2011-2014
  • Table 6.30 Selected Ethypharm's Pain Relieving Products, 2015
  • Table 7.1 SWOT Analysis of the Drug Delivery Technology Market, 2015-2025

List of Figures

  • Figure 1.1 South Korea Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), 2014-2025
  • Figure 1.2 Global Drug Delivery Technology Market Segmentation Overview 2015
  • Figure 3.1 The Drug Delivery Technology Market: Revenue ($bn), AGR (%), 2014-2025
  • Figure 3.2 Market Shares (%) of Leading Drug Delivery Market Segments, 2014
  • Figure 3.3 Market Shares (%) of Leading Drug Delivery Market Segments, 2019
  • Figure 3.4 Market Shares (%) of Leading Drug Delivery Market Segments, 2025
  • Figure 3.5 Global Biological Drugs Market: Revenues ($bn), AGR (%), 2012-2023
  • Figure 3.6 Global Vaccines Market: Revenues ($bn), AGR (%), 2014-2025
  • Figure 3.7 Drug Delivery Technologies: Market Drivers and Restraints 2015-2025
  • Figure 4.1 Oral Drug Delivery Technology Market: Revenue ($bn), AGR (%), 2014-2025
  • Figure 4.2 Oral Drug Delivery Technologies: Drivers and Restraints 2015-2025
  • Figure 4.3 Inhalable Drug Delivery Technology Market: Revenue ($bn), AGR (%), 2014-2025
  • Figure 4.4 Inhalable Drug Delivery Technologies: Drivers and Restraints 2015-2025
  • Figure 4.5 Injectable/Implantable Drug Delivery Technology Market: Revenue ($bn), AGR (%), 2014-2025
  • Figure 4.6 Injectable/Implantable Drug Delivery Technologies: Drivers and Restraints 2015-2025
  • Figure 4.7 Transdermal Drug Delivery Technology Market: Revenue ($bn), AGR (%), 2014-2025
  • Figure 4.8 Ocular Drug Delivery Technology Market: Revenue ($bn), AGR (%), 2014-2025
  • Figure 4.9 Nasal/Buccal Drug Delivery Technology Market: Revenue ($bn), AGR (%), 2014-2025
  • Figure 5.1 World Drug Delivery Technology Market: Revenues ($bn) by Region, 2014
  • Figure 5.2 World Drug Delivery Technology Market: Revenues ($bn) by Region, 2014-2025
  • Figure 5.3 World Drug Delivery Technology Market: Market Shares (%) by Regional Market, 2014
  • Figure 5.4 World Drug Delivery Technology Market: Market Shares (%) by Regional Market, 2019
  • Figure 5.5 World Drug Delivery Technology Market: Market Shares (%) by Regional Market, 2025
  • Figure 5.6 US Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), 2014-2025
  • Figure 5.7 EU5 Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), 2014-2025
  • Figure 5.8 EU5 Drug Delivery Technology Market: Market Shares (%) by National Market, 2014
  • Figure 5.9 EU5 Drug Delivery Technology Market: Market Shares (%) by National Market, 2019
  • Figure 5.10 EU5 Drug Delivery Technology Market: Market Shares (%) by National Market, 2025
  • Figure 5.11 German Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), 2014-2025
  • Figure 5.12 French Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), 2014-2025
  • Figure 5.13 UK Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), 2014-2025
  • Figure 5.14 Spanish Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), 2014-2025
  • Figure 5.15 Italian Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), 2014-2025
  • Figure 5.16 Japanese Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), 2014-2025
  • Figure 5.17 Chinese Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), 2014-2025
  • Figure 5.18 Indian Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), 2014-2025
  • Figure 5.19 Brazilian Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), 2014-2025
  • Figure 5.20 Russian Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), 2014-2025
  • Figure 5.21 South Korean Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), 2014-2025
  • Figure 5.22 Mexican Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), 2014-2025
  • Figure 5.23 Rest of the World Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), 2014-2025
  • Figure 6.1 Alkermes: Revenue ($m), AGR (%), 2010-2014
  • Figure 6.2 Alkermes: Revenue ($m) by Type, 2010-2014
  • Figure 6.3 Alkermes: Manufacturing and royalty revenue ($m) by Product, 2010-2014
  • Figure 6.4 Alkermes: Revenue ($m) by Main Customers 2014
  • Figure 6.5 3M: Health Care Revenue ($m), AGR (%), 2009-2014
  • Figure 6.6 Skyepharma: Revenue ($m), AGR (%), 2010-2014
  • Figure 6.7 Skyepharma: Revenue ($m) by Income Stream, 2010-2014
  • Figure 6.8 BD: Revenue ($bn) by Geographic Region, 2012-2014
  • Figure 6.9 BD Medical: Revenue ($m), AGR (%), 2009-2014
  • Figure 6.10 Antares' Revenue from Major Customers, 2010-2014
  • Figure 6.11 Antares Pharma: Revenue ($m), AGR (%), 2010-2014
  • Figure 6.12 pSivida: Revenue ($m) by Income Stream, 2011-2014

Companies Listed

  • 3M
  • Acorda
  • Actavis
  • Adamis
  • Aleza Pharmaceuticals
  • Alkermes
  • Almirall
  • Alza
  • Antares Pharma
  • Applied Pharma Research
  • Aradigm
  • Astellas
  • AstraZeneca
  • Bayer HealthCare Pharmaceuticals
  • BD
  • Biogen
  • BioGeneration Ventures
  • Bioject Medical Technologies
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • CareFusion Corporation
  • Cephalon
  • Changchun BCHT
  • Chiesi
  • Cilag
  • Cima Labs
  • Clearside
  • Cosmo Pharmaceuticals
  • CRISI Medical Systems
  • CTCBIO
  • Daiichi
  • Elan Drug Technologies
  • Elcam Medical
  • Eli Lilly
  • Ethypharm
  • Ferring
  • Flamel
  • Genentech
  • GlaxoSmithKline
  • Glycologic
  • Google
  • GSK
  • Haselmeir
  • Horizon Pharma
  • ImmusanT
  • Innovent Biologics
  • Insmed
  • Invion
  • iScience Interventional Corporation
  • J&J
  • Janssen
  • JCR Pharmaceuticals
  • Kyorin
  • MannKind
  • Meda Pharmaceuticals
  • Medac
  • Medimetrics
  • MedImmune
  • MedSciences Capital
  • Merck Serono
  • Mucosis
  • Mundipharma
  • Nanopass Technologies
  • Nektar Therapeutics
  • Nexvax2
  • NHTherapeutics
  • Novartis
  • Novo Nordisk
  • NuPathe
  • NV NOM
  • OwenMumford
  • Pacira Pharmaceuticals
  • Pari Pharma
  • Permatec
  • Pfizer
  • PharmaJet
  • Presspart
  • ProStrakan
  • pSivida
  • Pulmagen
  • Ranbaxy
  • Rani Therapeutics
  • Recro Pharma
  • Regeneron Pharmaceuticals
  • Roche
  • Sandoz
  • Sanofi-Aventis
  • Santen
  • Shionogi
  • SHL Group
  • Shreya Life Sciences
  • Skyepharma
  • Smoofi
  • Spark Therapeutics
  • STADA Arzneimittel
  • Takeda
  • Teva
  • UU Holdings
  • Vetter Pharma
  • West Pharmaceuticals
  • Ypsomed

Other Organisations Mentioned in This Report

  • Emory University School of Medicine
  • Georgia Institute of Technology
  • Hospital for Special Surgery
  • University of Oxford
Back to Top